norcantharidin has been researched along with Nasopharyngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AW; Chen, MK; Chuang, YC; Hsi, YT; Hsieh, MJ; Lin, CC; Lin, SH; Lo, YS; Tseng, YS; Yu, CY | 1 |
1 other study(ies) available for norcantharidin and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Humans; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2018 |